RMD ResMed Inc. | US7611521078
Financials
Trends
Details
| Breakdown | 30.06.2027 | 30.06.2026 | Change % |
|---|---|---|---|
| Total Revenue | 5.967.775.320 | 5.650.556.670 | 5.61% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 12,08 | 11,12 | 8.59% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 6 | 12 | 50.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |